What can we help you find?

May 10, 2012 8:08 am ET

Celebrities Megan Hilty, Wilmer Valderrama, Val Chmerkovskiy, La La Anthony, and Ivan Nova Join Dr. Scholl’s^® in New York City to Send a Message that It’s Time for America to Get Up & Go!^™

A new nationwide survey commissioned by Merck, the maker of DR. SCHOLL’S
products, found that 9 of out 10 Americans (91%) have experienced some
type of foot pain, among those more than half (56%) have missed an event
or an activity due to foot problems, and four of 10 Americans believe
that foot aches and pains get in the way of walking more. The survey
also found that New York City tops the list of cities where Americans
‘walk the walk.’

“Our DR. SCHOLL’S ‘Get Up & Go!^™‘ survey found that
our active lifestyle has Americans with their feet on the ground – more
than four hours a day for a third of Americans,” said Jim Mackey, senior
vice president, U.S. Region Head, Merck Consumer Care. “Our feet are the
foundation to living an active, energetic lifestyle, and that’s why the
essence of the DR. SCHOLL’S brand is ‘Get Up & Go!^™‘. We
want to help Americans jump into life with both feet, because it all
starts from the ground up.”

Time to Get Moving

The survey revealed opportunities for Americans to live the active,
energetic lifestyle they deserve. Many men and women feel they are
missing small opportunities to move throughout their day. Nearly half of
Americans do not regularly take the stairs instead of an elevator or
escalator (47%). Even when a destination is within walking distance, 78%
are still choosing to drive, rather than to walk.

American Cities on the Move

The DR. SCHOLL’S “Get Up & Go!^™” survey also
examined activity levels and habits in the top 10 U.S. cities to uncover
which residents are on their feet the most and took into account a
variety of factors such as type of exercise, time spent on their feet,
willingness to take opportunities to walk more, and reported walking
speeds. The rankings are:

1. New York

2. Boston

3. Philadelphia

4. Chicago

5. San Francisco

6. Washington, D.C.

7. Los Angeles

8. Atlanta

9. Dallas

10. Houston

Residents in New York and D.C. are the most likely to choose to walk
than those in any other city: 75% in New York and 70% in D.C.
frequently choose to walk rather than take public transit when their
destination is within walking distance. Compared to their Northeast
counterparts, only 55% in Houston and 52% in Dallas frequently choose
to walk.

Making it Work…at Work

You may have a desk job, but it seems that even Americans who have a
desk and chair spend significant time on their feet. Many even break
the dress code at times to add a little comfort to their day.

Not Chained to their Desks. On average, Americans who work in an
office still spend about a quarter (23%) of their workday on their feet
or walking around.

Comfort Reigns. 69% of American office workers admit they’ve worn
shoes that weren’t right for the office, such as sneakers, since they
are more comfortable.Strutting in Style. 58% of women still wear
heels – at an average of once a week.But Comfort Mostly Trumps Style.
86% of women would choose to wear something more comfortable rather than
rock a pair of stylish, but uncomfortable, high heels.

Merck, the maker of DR. SCHOLL’S products, brought together celebrities
including Megan Hilty, Wilmer Valderrama, Val Chmerkovskiy, La La
Anthony and Ivan Nova in New York City, to celebrate being active and to
encourage people to do the things they love and want to do. At the
event, attendees played tennis, learned to ballroom dance and
participated in other energetic activities – all while wearing their DR.
SCHOLL’S insoles!

“I am constantly on the move and if I experience foot discomfort, it
makes my job really hard to do,” said Megan Hilty, from the NBC hit
series Smash. “I love that Dr. Scholl’s^® makes all types
of insoles and products that help me keep moving and feeling
comfortable. My feet are my foundation and they should always feel good!”

Survey Methodology

The DR. SCHOLL’S “Get Up & Go!^™” survey was
conducted by Wakefield Research (www.wakefieldresearch.com)
among 1,000 nationally representative American adults ages 18+, and
among 400 American adults ages 18+ in each of the top ten DMAs, between
March 12th and March 26th, 2012, using an email invitation and an online
survey.

Results of any sample are subject to sampling variation. The magnitude
of the variation is measurable and is affected by the number of
interviews and the level of the percentages expressing the results. For
the nationally representative sample of adults ages 18+, the chances are
95 in 100 that a survey result does not vary, plus or minus, by more
than 3.1 percentage points from the result that would be obtained if
interviews had been conducted with all persons in the universe
represented by the sample. For each individual DMA, the chances are 95
in 100 that a survey result does not vary, plus or minus, by more than
4.9 percentage points.

About Merck Consumer Care

Today’s Merck is a global healthcare leader working to help the world be
well. Merck Consumer Care is a subsidiary of Merck & Co., Inc. Each day,
millions count on one or more of our industry-leading brands that help
prevent or treat various common conditions. These include household
names such as CLARITIN^® for allergies, COPPERTONE^®
for sun care, DR. SCHOLL’S^® for foot care, and many more.
Merck. Be well. For more information, visit www.merck.com
and connect with us on Facebook.

Merck Forward-Looking Statement

This news release includes “forward-looking statements” within the
meaning of the safe harbor provisions of the United States Private
Securities Litigation Reform Act of 1995. Such statements may include,
but are not limited to, statements about the benefits of the merger
between Merck and Schering-Plough, including future financial and
operating results, the combined company’s plans, objectives,
expectations and intentions and other statements that are not historical
facts. Such statements are based upon the current beliefs and
expectations of Merck’s management and are subject to significant risks
and uncertainties. Actual results may differ from those set forth in the
forward-looking statements.

The following factors, among others, could cause actual results to
differ from those set forth in the forward-looking statements: the
possibility that all of the expected synergies from the merger of Merck
and Schering-Plough will not be realized, or will not be realized within
the expected time period; the impact of pharmaceutical industry
regulation and health care legislation in the United States and
internationally; Merck’s ability to accurately predict future market
conditions; dependence on the effectiveness of Merck’s patents and other
protections for innovative products; and the exposure to litigation
and/or regulatory actions.

Merck undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise. Additional factors that could cause results to differ
materially from those described in the forward-looking statements can be
found in Merck’s 2011 Annual Report on Form 10-K and the company’s other
filings with the Securities and Exchange Commission (SEC) available at
the SEC’s Internet site (www.sec.gov).